ATEC logo

ALPHATEC HOLDINGS INC

ATECNASDAQ
πŸ† #2004 by market capEarnings Oct 29US Equity
$9.26β–Ό $0.11 (βˆ’1.17%)
Live
1hβ–² 0.7%
24hβ–Ό 1.2%
7dβ–Ό 3.0%
14dβ–Ό 4.1%
30dβ–Ό 4.9%
1yβ–Ό 41.1%
🏦Market Cap
$1.42B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+24.9%
Healthy
πŸ“ŠGross Margin
66.2%
High
πŸ’΅FCF Margin
0.5%
Thin
βš–οΈP/S Ratio
1.8x
Cheap
Otter Score
41
Weak

Trading Snapshot

Day Range
$9.13 – $9.42
52-Week Range
$6.82 – $23.29
Volume
$1.97B
Avg Volume
$2.02B
Shares Outstanding
153.8M
Next Earnings
Oct 23, 2026

Fundamentals Snapshot

Annual Revenue
$764M
Last Q Revenue
$214M
P/E Ratio
-13.0
P/S Ratio
1.8x
EPS (TTM)
$-0.71
Dividend Yield
0.00%

Why Investors Own ATEC

  • βœ“High-growth profile β€” revenue up +37.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 39% gross margin and 9% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$764Mβ–² +43.7% YoY
Gross Margin (TTM)
38.8%β–² +3.2% YoY
Operating Income (TTM)
$215Mβ–² +43.7% YoY
Free Cash Flow (TTM)
$70Mβ–² +43.7% YoY

About ALPHATEC HOLDINGS INC

Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
41/100

Analyst Price Target

β“˜
Average Target
$11.72
β–² +26.5% Upside
High Target$12.84
Low Target$10.80
Based on 25 analysts

Latest News & Updates